Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 July 2021 | Story Ruan Bruwer | Photo UFS Photo Archive

Two athletes, both employees of the University of the Free State (UFS), are now giving back to the sport in administrative roles.

Kesa Molotsane and Louzanne Coetzee are making time in their work and training schedules to serve the sports in which they have represented their country – Molotsane in cross-country and Coetzee in the 1 500 m and 800 m T11 category for athletes with a disability.

Louzanne_web content
Louzanne Coetzee Photo: UFS Photo Archive 

Coetzee is again heading for the Paralympic Games in Tokyo. She is a nominee for the International Paralympic Committee Athletes’ Council. Six representatives will be chosen at the Paralympics.

Coetzee was recently elected to the South African Sports Confederation and Olympic Committee Athletes’ Commission. She is also an athlete representative of the South African Sports Association for Physically Disabled.

Molotsane was co-opted into the National Executive Committee of University Sport South Africa as an assessor. She is also the new vice-chairperson of the Athletics South Africa Athletes Commission.

Kesa Molotsane_content
Kesa Molotsane. Photo: Supplied

“My biggest dream is to enable athletes to dream big, and for their dreams to be recognised. I would like to see them enjoy their sport,” said Molotsane.

“I think I probably missed a lot of opportunities in my career due to a lack of funding, so I don’t want to see anyone face the same situation.”

Molotsane was also recently named as one of two ambassadors for the SPAR Grand Prix Series. 

According to Coetzee, a former member of the Student Representative Council at the UFS, she believes that it is important for a current sportsperson to contribute and give input in their sport. 

“I enjoy leadership, it is perhaps a gift of mine. Serving the sport in that capacity is not something that is too much of an effort or takes too much of my time. I enjoy contributing and to see something move in a direction.”

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept